Attendees are posing after a medical business briefing session held at AdipoLABs headquarters.

【Health News】 AdipoLABs, company that treats cancer patients around the world by developing high-frequency hyperthermia cancer treatment device of REMISSION 1℃ with pure domestic technology, will supply the device to Thailand’s largest resort villa complex.

AdipoLABs Co., Ltd. (CEO Han Sung-ho) announced that the company held a medical business briefing session at its headquarters office on the 12th with Michael Ma, Chairman of Indochine Resort & Villas, Phuket, Thailand.

AdipoLABs Co., Ltd. (CEO Han Sung-ho) announced that the company held a medical business briefing session at its headquarters office on the 12th with Michael Ma, Chairman of Indochine Resort & Villas, Phuket, Thailand.

Chairman Michael is the Chairman of Indochine, which operates the largest resort villa complex in Thailand, and operates the Indochine chain in five countries around the world.

Chairman Michael's visit to the AdipoLABs headquarters is part of a plan to develop a resort, hotel, sports center, and medical retreat hospital on 16,500,000 square feet of land in Phuket.

In particular, AdipoLABs' high-frequency hyperthermia cancer treatment device REMISSION 1℃ will be used as a core treatment device in the opening of a medical resort hospital.

At the briefing session on this day, Dr. Kim Eui-shin, a world-renowned medical scholar and lifetime professor at MD Anderson, Professor Jang Hong-seok of the Department of Radiation Oncology at Seoul St. Mary's Hospital, Director Yoo Seung-mo of Yesan Myeongji Hospital, Director Kim Seon-man of Amirang Clinic, which operates the largest number of high-frequency medical devices in Korea, and IVRA (International Virus Resaerch Alliance) Officials, Hana Bank Executive Director Park Jae-hyun, and public relations ambassador singer Norazo attended and exchanged opinions on forming a medical center.

link: [후생신보] 아디포랩스 ‘리미션1℃’ 태국 최대 리조트 ‘푸켓 인도치네’ 진출 (whosaeng.com)